Cargando…
The use of Esketamine in CT-guided percutaneous liver tumor ablation reduces the consumption of remifentanil: a randomized, controlled, double-blind trial
BACKGROUND: In the anesthesia management of percutaneous liver tumor ablation, the requirement of analgesia is very strict. Currently, intravenous anesthesia is commonly used, such as remifentanil combined with sedative drugs. However, the pain relief is not instantaneous after increasing the dosage...
Autores principales: | Su, Yanbing, Zhang, Jianxing, Wang, Huanwei, Gu, Yangkui, Ouyang, Handong, Huang, Wan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279786/ https://www.ncbi.nlm.nih.gov/pubmed/35845514 http://dx.doi.org/10.21037/atm-22-2756 |
Ejemplares similares
-
Comparison of remifentanil and esketamine in combination with propofol for patient sedation during fiberoptic bronchoscopy
por: Nie, Jia, et al.
Publicado: (2023) -
A comparative study of esketamine-dexmedetomidine and sufentanil-dexmedetomidine for sedation and analgesia in lung tumor percutaneous radiofrequency ablation (PRFA): a randomized double-blind clinical trial
por: Lin, Zhonglan, et al.
Publicado: (2023) -
A Comparison of Intranasal Dexmedetomidine, Esketamine or a Dexmedetomidine-Esketamine Combination for Induction of Anaesthesia in Children: A Randomized Controlled Double-Blind Trial
por: Lu, Xinlei, et al.
Publicado: (2022) -
Analgesic effects of dexmedetomidine and remifentanil on periprocedural pain during percutaneous ablation of renal carcinoma
por: Semenas, Egidijus, et al.
Publicado: (2020) -
CT-Guided Percutaneous Microwave Ablation of Sclerosing Hepatic Carcinoma
por: Song, Hongshen, et al.
Publicado: (2020)